Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 microg and fluticasone pr (Q33420122)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 microg and fluticasone pr |
scientific article |
Statements
1 reference
Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 microg and fluticasone pr (English)
1 reference
Peter T Daley-Yates
1 reference
David A Parkins
1 reference
Marian J Thomas
1 reference
Benjamin Gillett
1 reference
Karen W House
1 reference
Hector G Ortega
1 reference
1 February 2009
1 reference
1 reference
Identifiers
1 reference